US 11,878,040 B2
Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin
Valeria Longoni, Latina (IT); and Marisa Penci, Latina (IT)
Assigned to GLAXOSMITHKLINE CONSUMER HEALTHCARE S.R.L., Bucharest (RO)
Filed by GlaxoSmithKline Consumer Healthcare S.R.L., Bucharest (RO)
Filed on Aug. 31, 2022, as Appl. No. 17/823,530.
Application 17/823,530 is a continuation of application No. 15/485,809, filed on Apr. 12, 2017, granted, now 11,478,515.
Application 15/485,809 is a continuation of application No. 13/179,712, filed on Jul. 11, 2011, granted, now 9,649,380, issued on May 16, 2017.
Application 13/179,712 is a continuation in part of application No. PCT/US2010/020712, filed on Jan. 12, 2010.
Claims priority of application No. MI2009A000019 (IT), filed on Jan. 12, 2009.
Prior Publication US 2023/0045437 A1, Feb. 9, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 35/745 (2015.01); A23L 33/135 (2016.01); A23L 33/16 (2016.01); A23L 33/19 (2016.01); A23L 33/21 (2016.01); A61K 35/747 (2015.01); A61K 38/06 (2006.01); A61K 38/40 (2006.01); A61K 9/00 (2006.01); A61K 47/26 (2006.01); A61K 47/42 (2017.01); A61K 47/20 (2006.01); A61K 31/733 (2006.01); A61K 47/02 (2006.01); A61K 36/064 (2006.01); A61K 47/36 (2006.01); A61K 35/00 (2006.01)
CPC A61K 35/745 (2013.01) [A23L 33/135 (2016.08); A23L 33/16 (2016.08); A23L 33/19 (2016.08); A23L 33/21 (2016.08); A61K 9/0095 (2013.01); A61K 31/733 (2013.01); A61K 35/747 (2013.01); A61K 36/064 (2013.01); A61K 38/063 (2013.01); A61K 38/40 (2013.01); A61K 47/02 (2013.01); A61K 47/20 (2013.01); A61K 47/26 (2013.01); A61K 47/36 (2013.01); A61K 47/42 (2013.01); A23V 2002/00 (2013.01); A61K 2035/11 (2013.01)] 12 Claims
 
1. A probiotic composition for oral administration comprising:
at least about 50 billion CFU/g Bifidobacterium longum R175;
at least about 150 billion CFU/g Lactobacillus helveticus R52;
at least about 150 billion CFU/g Lactobacillus plantarum R1012;
one or more prebiotic components selected from inulin, fructose, fructooligosaccharides and mixtures thereof;
one or more metal salts selected from the group consisting of magnesium gluconate, potassium citrate, copper citrate and zinc gluconate; and
one or more excipients.